Jasmine Cui – Founder & CEO, Innocare
After a glittering career in corporate America, in 2011 Jasmine Cui returned to China and in 2015 launched her own biotech, Innocare. The firm, which focuses on oncology and autoimmune…
Address: Suite 2202, Level 22, 141 Walker Street, North Sydney NSW 2060,Australia
Tel: +61 2 9922 5111
Web: http://www.asmi.com.au/home/
ASMI is the peak body representing companies involved in the manufacture and distribution of consumer healthcare products in Australia. Since its establishment in 1974, the Association has focussed its efforts on supporting the progress and development of the Self Care products industry, including both OTCs and complementary products.
Our purpose is to promote the best interests of our Members through negotiation, debate and cooperation with a wide range of stakeholders in our own region and around the world. We also gather the best and most current information from diverse sources and disseminate it to our Members to alert them to potential issues that may affect their product or its market.
ASMI is a member of the World Self-Medication Industry (WSMI) and our President and Executive Director sit on the Board of that organisation. WSMI is a non-government organisation made up of over 50 member associations located on all continents of the World, with affiliations to the World Health Organization (WHO). Our membership of WSMI enables us to track and contribute to international trends and developments in consumer healthcare.
ASMI – the voice of the consumer Self Care products industry, driving a credible and expanding evidence-based self-medication market to generate cost-effective health solutions and improved public health outcomes.
After a glittering career in corporate America, in 2011 Jasmine Cui returned to China and in 2015 launched her own biotech, Innocare. The firm, which focuses on oncology and autoimmune…
Medaxes – the Belgian industry association for companies producing generic and biosimilar medicines, as well as other off-patent medicines and self-care products – welcomed a new CEO in 2022, Jasmien…
As a general medical practitioner with a long experience in the pharmaceutical industry including public policy, advertising, marketing and regulatory issues and a post graduate training in traditional Chinese medicine,…
Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international presence. Could you introduce the story behind such achievements?…
In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of New South Wales, Medicine, St. Vincent’s Hospital) and John Skeritt, Head of Australia’s Therapeutic Goods Administration (TGA),…
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices is beneficial to patients, companies and healthcare systems as a whole. Goodwin also gives his five…
Can you start by giving our readers a brief overview of the company’s history here and your most notable achievements? Initially the company was founded as a small distributor of…
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting recent milestones & achievements? George Clinical is an important division of the Institute,…
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in 2011. Can you please begin with giving our readers an introduction to…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent milestones & achievements and the current focus areas of its research activities? Broadly speaking,…
For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in cardiovascular physiology I moved to Boston to work at MIT…
In some ways the Australian medicines industry is going through the same restructuring and challenges as the industry is going through globally: the country deals with patent cliffs, companies are…
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After traveling the world, the Australian market has shown to be one of…
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in providing space for innovative medicine listings, and that…
Dr Bernadette Morris-Smith has also participated in this interview TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would you begin…
See our Cookie Privacy Policy Here
